Relenza Use In U.K. For 2000 Season Will Await Four Ongoing Glaxo Trials

A recommendation in favor of prescribing Glaxo Wellcome's influenza therapy Relenza on the U.K.' s National Health Service for the 2000-20001 flu season will await the results of four ongoing trials, according to a report issued Oct. 8 by the National Institute for Clinical Excellence.